Skip to main content
Premium Trial:

Request an Annual Quote

Strand Genomics Pockets $4.6M in First VC Financing Round

NEW YORK, Sept. 19 - Strand Genomics today said it has secured $4.6 million in its first private-equity financing round.


WestBridge Capital Partners, based in San Francisco, led the round, which included an investment by UVI Venture Funds and angel investors, Strand said.


Strand Genomics will use the money to "expand" its presence in Europe and develop a platform to analyze ADME and associated toxicology properties of molecules, among other things, according to Sreeni Devidas, the firm's vice president of business development and strategy.


Click here for more information.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.